Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody

Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody

US Patent 12303521 · Granted May 20, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Base-modified cytidine nucleotides for leukemia therapy2025
Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination thera2021
Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug 2019